Navigation Links
CEL-SCI Corporation Announces 2008 Financial Results
Date:1/14/2009

2008 2007 GRANT REVENUE AND OTHER $5,065 $57,043 OPERATING EXPENSES: Research and development (excluding R&D depreciation of $124,705 and $91,292 respectively, included below) 4,101,563 2,528,528 Depreciation and amortization 215,060 176,186 General & administrative 5,200,735 6,704,538 Total operating expenses 9,517,358 9,409,252 NET OPERATING LOSS (9,512,293) (9,352,209) GAIN ON DERIVATIVE INSTRUMENTS 1,799,393 868,182 COSTS ASSOCIATED WITH CONVERTIBLE DEBT - - INTEREST INCOME 483,252 562,973 INTEREST EXPENSE (473,767) (1,708,603) NET LOSS $(7,703,415) $(9,629,657) DIVIDENDS (424,815) - NET LOSS AVAILABLE TO COMMON SHAREHOLDERS $(8,128,230) $(9,629,657) NET LOSS PER COMMON SHARE BASIC $(0.07) $(0.10) DILUTED $(0.07) $(0.10) WEIGHTED AVERAGE COMMON SHARES OUTSTANDING BASIC 117,060,866 97,310,488 DILUTED 117,060,866 97,310,488


'/>"/>
SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. CEL-SCI Corporation Releases Letter to Shareholders
2. Updated Pictures of CEL-SCI Manufacturing Facility Available Online
3. CEL-SCI Takes Delivery of New Manufacturing Facility
4. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
5. CEL-SCI Announces Exclusive Licensing Agreement with Teva for Cancer Drug Multikine
6. CEL-SCI CORPORATION Manufacturing Facility for Pivotal Phase III Cancer Trial Scheduled to Be Completed During 2008 Third Quarter
7. CEL-SCI to Present at the Noble Financial Conference
8. Volcano Corporation Presentation at J.P. Morgan Conference to be Webcast
9. Mach One Corporation Enters Letter of Intent
10. Shareholder Class Action Filed Against Elan Corporation, plc by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
11. Environmental Tectonics Corporation Announces Placement of Two Monoplace Chambers at St. John Wound Center; First Computer-controlled Hyperbaric Chambers in Oklahoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015  Faced with increasing ... are palliative rather than symptomatic, the global healthcare ... existing therapies capable of curing or significantly changing ... starting to look towards regenerative medicine as a ... new paradigm in human health with the potential ...
(Date:7/27/2015)... ... July 27, 2015 , ... Production of high tenacity ... past few years in the EU. For instance, it surpassed the EUR 106 million ... million mark in 2010. Germany is a major producer, while Italy is a key ...
(Date:7/27/2015)... , July 27, 2015 According ... by Type (Home-brew Media, Pre-formulated Media), by Application (Biobanking, Regenerative ... , Europe , Asia-Pacific ... 2019", The global biopreservation media market was valued at $247.7 ... $571.5 million by 2019, at a CAGR of 18.2% between ...
(Date:7/26/2015)... ... July 26, 2015 , ... Maine Standards Company, LLC ... linearity test kit. The VALIDATE® ANEMIA kit contains Ferritin, Folate, and Vitamin B12 ... the CLSI recommended “equal delta” method for linearity testing and is liquid, ready-to-use. ...
Breaking Biology Technology:Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 5High Tenacity Filament Yarn of Viscose Rayon Consumption to Grow Swiftly in the EU, Forecasts BAC Reports in New Study Available at MarketPublishers.com 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 3Maine Standards Company, LLC Announces Release of VALIDATE® ANEMIA Calibration Verification / Linearity Test Kit 2
... , , ... , The ribonuclease protection assay (RPA) ... mRNA species. The assay was made possible,by the discovery and characterization ... properties that,make them well suited for the preparation of highly specific,hybridization ...
... , , , Product Literature Center Articles , ... , , ... Expression Patterns with Improved Tools for Target Amplification , , ... with FastStart Taq DNA Polymerase and the Novel FastStart High Fidelity PCR System , ...
... , , , ... , Like all components of a PCR or RT-PCR assay, ... DNA, RNA, nucleases,or a variety of microorganisms. These contaminants,often contribute to suboptimal amplification ... , , Roche Applied Sciences LightCycler Kits ...
Cached Biology Technology:RNase Protection Assay (RPA),Using DIG-Labeled RNA Probes 2Roche Diagnostics Corporation 2Roche Diagnostics Corporation 3Roche Diagnostics Corporation 4Roche Diagnostics Corporation 5Enjoy a Greater Sense of Security,with PCR-Grade Water 2
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/jvft55/next_generation ... Generation Biometrics Market by Application, Technology, Function & Geography ... offering. The next generation biometrics market is ... CAGR of 17.9% between 2015 and 2020 ... market. Safran SA ( France ...
(Date:6/29/2015)... DUBLIN , June 24, 2015 ... the addition of the "Latin America Biomedical Sensors ... to their offering. The Latin America Biomedical ... at a CAGR of 2.04% over the period 2014-2020 ... that are adaptable to the genetic formulation of each ...
(Date:6/25/2015)... -- TAKE Solutions Ltd., a global business technology solutions provider, ... and Trademark Office (USPTO) for its "Method for Optimizing ... Accelerators to reduce the time taken to standardize trial ... the accelerators), thus reducing time to market. ... heart of the patented Clinical Data Standardization Process are ...
Breaking Biology News(10 mins):Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3Latin America Biomedical Sensors Market Report 2015-2020 2TAKE Solutions Awarded Patent By USPTO 2
... Molecular and Cell Biology (IMCB) and the Singapore Bioimaging ... controls both obesity and atherosclerosis. The team demonstrated, for ... gene were resistant to weight gain and atherosclerosis via ... its downstream signalling molecule mTor. These groundbreaking findings were ...
... Function and significance of the biological clocks in polar ... Institute entitled PolarTime starting July 1st, 2012. It is ... Helmholtz Association. PolarTime, coordinated by the Alfred Wegener Institute ... up to five years with approximately three million euros ...
... in German . , One bit of ... about 3 million magnetic atoms. Researchers from Karlsruhe, Strasbourg, and ... per molecule. By an electric pulse, the metal-organic molecule can ... low-conductive, non-magnetic state. This novel correlation for molecules is now ...
Cached Biology News:Groundbreaking discovery of mechanism that controls obesity, atherosclerosis 2Just a question of time? 2Just a question of time? 3Nature: Molecule changes magnetism and conductance 2
... J. Karn (1995) This volume ... and methods for the study of major ... reverse transcriptase, ribonuclease H, integrase and protease. ... binding assays; Tat and Rev assays; HIV/CD4 ...
Monkey IL-2 ELISPOT Kit with white/opague microtiter plates...
Tachykinin (H-2)...
Human GATA-2 Affinity Purified Polyclonal Ab...
Biology Products: